Skip to main content
. 2022 Nov 23;10(5):2082–2096. doi: 10.1016/j.gendis.2022.10.021

Figure 7.

Fig. 7

LRP1B regulates the ubiquitination, degradation, and protein level of NCSTN. (A) The rate of NCSTN degradation after cycloheximide (CHX) inhibition of protein synthesis. (B)NCSTN protein levels were determined after MG132 treatment. (C) The proteasome inhibitor MG132 restored the LRP1B-mediated reduction in the NCSTN protein level in cancer cells. (D)LRP1B regulates the ubiquitination of NCSTN.